|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/28 | (2013.01) | ||
| C12N 15/13 | (2006.01) | ||
| A61K 39/395 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3569616 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17891529.4 |
| Europos patento paraiškos padavimo data | 2017-01-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-11-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2017/071125 |
| Data | 2017-01-13 |
| (87) | Numeris | WO 2018/129714 |
| Data | 2018-07-19 |
| (72) |
ZHANG, Faming , CN
XI, Gan , CN
HUANG, Ying , CN
XIA, Yu , CN
LI, Baiyong , CN
WANG, Zhongmin Maxwell , CN
|
| (73) |
Taizhou Hanzhong Biopharmaceutics, Inc. ,
No.1 of China Medical City Road, Taizhou, Jiangsu 225316,
CN
Akeso Biopharma Inc. , 6 Shennong Boulevard Torch Developmental Zone, Zhongshan, Guangdong 528437, CN |
| (54) | MONOCLONAL ANTIBODY AGAINST PD-1 AND APPLICATIONS THEREOF |
| MONOCLONAL ANTIBODY AGAINST PD-1 AND APPLICATIONS THEREOF |